Suppr超能文献

白细胞介素-2 在效应反应、耐受和免疫治疗的十字路口。

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

机构信息

Laboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1674, USA.

出版信息

Immunity. 2013 Jan 24;38(1):13-25. doi: 10.1016/j.immuni.2013.01.004.

Abstract

Interleukin-2 (IL-2) is a pleiotropic cytokine produced after antigen activation that plays pivotal roles in the immune response. Discovered as a T cell growth factor, IL-2 additionally promotes CD8(+) T cell and natural killer cell cytolytic activity and modulates T cell differentiation programs in response to antigen, promoting naïve CD4(+) T cell differentiation into T helper 1 (Th1) and T helper 2 (Th2) cells while inhibiting T helper 17 (Th17) and T follicular helper (Tfh) cell differentiation. Moreover, IL-2 is essential for the development and maintenance of T regulatory cells and for activation-induced cell death, thereby mediating tolerance and limiting inappropriate immune reactions. In this review, we focus on the molecular mechanisms and complex cellular actions of IL-2, its cooperative and opposing effects with other cytokines, and how both promoting and blocking the actions of IL-2 are being utilized in clinical medicine.

摘要

白细胞介素-2(IL-2)是一种抗原激活后产生的多效细胞因子,在免疫反应中发挥关键作用。作为一种 T 细胞生长因子被发现,IL-2 还促进 CD8(+) T 细胞和自然杀伤细胞的细胞溶解活性,并调节 T 细胞分化程序以响应抗原,促进幼稚 CD4(+) T 细胞分化为辅助性 T 细胞 1(Th1)和辅助性 T 细胞 2(Th2)细胞,同时抑制辅助性 T 细胞 17(Th17)和滤泡辅助性 T(Tfh)细胞分化。此外,IL-2 对于 T 调节细胞的发育和维持以及激活诱导的细胞死亡是必需的,从而介导耐受并限制不适当的免疫反应。在这篇综述中,我们重点关注 IL-2 的分子机制和复杂的细胞作用、它与其他细胞因子的协同和拮抗作用,以及如何促进和阻断 IL-2 的作用在临床医学中的应用。

相似文献

1
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.
Immunity. 2013 Jan 24;38(1):13-25. doi: 10.1016/j.immuni.2013.01.004.
2
In Vitro Differentiation of Effector CD4 T Helper Cell Subsets.
Methods Mol Biol. 2019;1960:75-84. doi: 10.1007/978-1-4939-9167-9_6.
3
IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation.
Curr Opin Immunol. 2011 Oct;23(5):598-604. doi: 10.1016/j.coi.2011.08.003. Epub 2011 Aug 31.
4
IL-2, IL-7, and IL-15: Multistage regulators of CD4(+) T helper cell differentiation.
Exp Hematol. 2016 Sep;44(9):799-808. doi: 10.1016/j.exphem.2016.06.003. Epub 2016 Jul 15.
6
CD25(+) Bcl6(low) T follicular helper cells provide help to maturing B cells in germinal centers of human tonsil.
Eur J Immunol. 2015 Jan;45(1):298-308. doi: 10.1002/eji.201444911. Epub 2014 Oct 27.
9
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
J Immunol. 2006 Jun 15;176(12):7288-300. doi: 10.4049/jimmunol.176.12.7288.

引用本文的文献

3
Novel IL13RA2-targeted immunocytokines exhibit superior antitumor activities.
Acta Pharmacol Sin. 2025 Aug 12. doi: 10.1038/s41401-025-01611-w.
5
The prognostic and predictive value of peripheral immune-related proteins in patients with lung cancer treated with radiotherapy.
Front Oncol. 2025 Jul 17;15:1625212. doi: 10.3389/fonc.2025.1625212. eCollection 2025.
6
BLIMP1 negatively regulates IL-2 signaling in T cells.
Sci Adv. 2025 Jul 18;11(29):eadx8105. doi: 10.1126/sciadv.adx8105.
7
The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.
J Immunol Res. 2025 Jul 2;2025:8890939. doi: 10.1155/jimr/8890939. eCollection 2025.
8
T cell-derived small extracellular vesicles in cancer-immune interactions.
Cancer Immunol Immunother. 2025 Jun 25;74(8):252. doi: 10.1007/s00262-025-04109-w.
9
Engineered bacteria: Strategies and applications in cancer immunotherapy.
Fundam Res. 2024 Nov 13;5(3):1327-1345. doi: 10.1016/j.fmre.2024.11.001. eCollection 2025 May.
10
In Vivo Accumulation of Regulatory T Cells Using Eliglustat-Loaded Cryogels.
Adv Healthc Mater. 2025 Jun 17:e2501529. doi: 10.1002/adhm.202501529.

本文引用的文献

3
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15.
Nat Immunol. 2012 Dec;13(12):1187-95. doi: 10.1038/ni.2449. Epub 2012 Oct 28.
4
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.
Curr Opin Pharmacol. 2012 Aug;12(4):464-70. doi: 10.1016/j.coph.2012.06.008. Epub 2012 Jul 19.
5
Aiolos promotes TH17 differentiation by directly silencing Il2 expression.
Nat Immunol. 2012 Jul 1;13(8):770-7. doi: 10.1038/ni.2363.
6
Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1.
Immunity. 2012 Jun 29;36(6):921-32. doi: 10.1016/j.immuni.2012.04.006. Epub 2012 May 17.
7
miR-9 enhances IL-2 production in activated human CD4(+) T cells by repressing Blimp-1.
Eur J Immunol. 2012 Aug;42(8):2100-8. doi: 10.1002/eji.201142203.
8
TRIM28 prevents autoinflammatory T cell development in vivo.
Nat Immunol. 2012 Apr 29;13(6):596-603. doi: 10.1038/ni.2293.
10
Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation.
Immunity. 2012 May 25;36(5):847-56. doi: 10.1016/j.immuni.2012.02.012. Epub 2012 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验